UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

British journal of cancer, 2011-03, Vol.104 (5), p.863-870

2011

Volltextzugriff (PDF)

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gynecologic oncology, 2013-10, Vol.131 (1), p.15-20

2013

Volltextzugriff (PDF)

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Annals of oncology, 2012-07, Vol.23 (7), p.1795-1802

2012

Volltextzugriff (PDF)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

The New England journal of medicine, 2024-02, Vol.390 (9), p.819

2024

Volltextzugriff (PDF)

0283: Phase II Study of the “Leuven” Weekly Paclitaxel/Carboplatin Regimen in 31 Patients with Recurrent Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.681-681

2006

Volltextzugriff (PDF)

Intrauterine device (IUD) migration in cesarean delivery scar: What to do with the niche?

Facts, views & vision in ObGyn, 2019-09, Vol.11 (3), p.251-256

2019

Volltextzugriff (PDF)

AGGRESSIVE BIOLOGIC BEHAVIOR OF ENDOMETRIAL CARCINOSARCOMA WHEN COMPARED TO HIGH RISK EPITHELIAL ENDOMETRIAL CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.124-124

2004

Volltextzugriff (PDF)

THE DIAGNOSTIC PROBLEM OF ENDOMETRIAL STROMAL SARCOMA: REPORT ON SIX CASES

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.15-15

2003

Volltextzugriff (PDF)

ENDOMETRIAL STROMAL SARCOMA WITH A SOLE T(X;17) CHROMOSOME CHANGE

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.71-71

2003

Volltextzugriff (PDF)

THE IMPORTANCE OF HORMONES IN THE TREATMENT OF ENDOMETRIAL STROMAL SARCOMA: AN UPDATE

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.70-70

2003

Volltextzugriff (PDF)

The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles

Anticancer research, 2009-04, Vol.29 (4), p.1039-1045

2009

Volltextzugriff (PDF)

HE4 and CA I25 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

British journal of cancer, 2011, Vol.104 (5), p.863-870

2011

Volltextzugriff (PDF)

[Delta]133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593

2011

Volltextzugriff (PDF)

Use of HE4 expression in plasma to predict operative outcome in patients with ovarian cancer (OC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5022-5022

2010

Volltextzugriff (PDF)

Δ 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Prognostische Bedeutung des postoperativen Tumorrests bei Patientinnen mit epithelialem Ovarialkarzinom FIGO IIA-IV: Analyse der OVCAD Daten

Geburtshilfe und Frauenheilkunde, 2012, Vol.72 (4)

2012

Volltextzugriff (PDF)

Molekulare Subklassifizierung als unabhängiger Prognosefaktor bei Patientinnen mit Ovarialkarzinom – eine Studie des OVCAD Konsortiums

Geburtshilfe und Frauenheilkunde, 2011, Vol.71 (8)

2011

Volltextzugriff (PDF)

Molekulare Subklassifizierung als unabhängiger Prognosefaktor bei Patientinnen mit Ovarialkarzinom – eine Studie des OVCAD Konsortiums

Geburtshilfe und Frauenheilkunde, 2011, Vol.71 (5)

2011

Volltextzugriff (PDF)

Intrauterine device (IUD) migration in cesarean delivery scar: What to do with the niche?

Facts, views & vision in ObGyn, 2019, Vol.11 (3), p.251-256

2019

Volltextzugriff (PDF)

Predictive Models for Long Term Survival after Premature Rupture of Membranes

2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, 2005, Vol.2005, p.4622-4625

2005

Volltextzugriff (PDF)

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

European journal of cancer (1990), 2012-07, Vol.48 (11), p.1649-1656

2012

Volltextzugriff (PDF)

Management of Borderline Ovarian Neoplasms

Journal of clinical oncology, 2007-07, Vol.25 (20), p.2928-2937

2007

Volltextzugriff (PDF)

Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy

PloS one, 2015-04, Vol.10 (4), p.e0126222-e0126222

2015

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(33)
Female
(32)
Oncology
(30)
Middle Aged
(19)
Obstetrics & Gynecology
(18)
Ovarian Cancer
(16)
Ovarian Neoplasms - Pathology
(16)
Adult
(15)
Prognosis
(14)
Aged
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Tumors
(13)
Hematology, Oncology And Palliative Medicine
(12)
Ovarian Neoplasms - Drug Therapy
(10)
Aged, 80 And Over
(9)
Female Genital Diseases
(9)
Gynecology. Andrology. Obstetrics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

0283: Phase II Study of the “Leuven” Weekly Paclitaxel/Carboplatin Regimen in 31 Patients with Recurrent Ovarian Cancer

Intrauterine device (IUD) migration in cesarean delivery scar: What to do with the niche?

AGGRESSIVE BIOLOGIC BEHAVIOR OF ENDOMETRIAL CARCINOSARCOMA WHEN COMPARED TO HIGH RISK EPITHELIAL ENDOMETRIAL CANCER

THE DIAGNOSTIC PROBLEM OF ENDOMETRIAL STROMAL SARCOMA: REPORT ON SIX CASES

ENDOMETRIAL STROMAL SARCOMA WITH A SOLE T(X;17) CHROMOSOME CHANGE

THE IMPORTANCE OF HORMONES IN THE TREATMENT OF ENDOMETRIAL STROMAL SARCOMA: AN UPDATE

The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles

HE4 and CA I25 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

[Delta]133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Use of HE4 expression in plasma to predict operative outcome in patients with ovarian cancer (OC)

Δ 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Prognostische Bedeutung des postoperativen Tumorrests bei Patientinnen mit epithelialem Ovarialkarzinom FIGO IIA-IV: Analyse der OVCAD Daten

Molekulare Subklassifizierung als unabhängiger Prognosefaktor bei Patientinnen mit Ovarialkarzinom – eine Studie des OVCAD Konsortiums

Molekulare Subklassifizierung als unabhängiger Prognosefaktor bei Patientinnen mit Ovarialkarzinom – eine Studie des OVCAD Konsortiums

Intrauterine device (IUD) migration in cesarean delivery scar: What to do with the niche?

Predictive Models for Long Term Survival after Premature Rupture of Membranes

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

Management of Borderline Ovarian Neoplasms

Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy

Suchergebnisse filtern